We compared the haemodynamic effects of nicardipine and sodium nitroprusside after coronary artery bypass graft surgery. When post-surgery systolic blood pressure reached > 150 mmHg, patients were randomly given nicardipine (N group, n = 26) or sodium nitroprusside (S group, n = 21). The drugs were infused at a rate of 2 µg/kg per min for 10 min. If the target blood pressure (120 -140 mmHg) was not achieved, the infusion rate was increased by 1 µg/kg per min every 10 min. Cardiac and stroke volume indices had increased significantly in the N group after 10 min and in both groups after 60 min. The infusion duration and total dose of drug were significantly lower in the N group compared with the S group. Nicardipine infusion controlled post-operative hypertension more rapidly and was superior to sodium nitroprusside in maintaining left ventricular performance immediately after drug infusion.
Introduction
Hypertension develops after coronary artery bypass graft surgery (CABG) in approximately 30 -70% of cases, and mostly occurs within 6 h of surgery. 1, 2 Causes of this rise in blood pressure include increased catecholamine levels, renin-angiotensin system activation, enhanced sympathetic reflex of the heart and other arteries, and decreased body temperature. 3, 4 Post-operative hypertension increases systemic vascular resistance (SVR), lowers left ventricular function, and can cause post-operative bleeding, arrhythmia, intracranial haemorrhage and myocardial infarction. 5, 6 Increased blood pressure immediately after CABG therefore requires prompt treatment.
Sodium nitroprusside (SNP) has generally been used to treat post-CABG hypertension because of its fast onset of action, short halflife and ease of dose adjustment. 7 -9 Despite short-term advantages, however, SNP may cause cyanide toxicity when used over extended periods, and may reduce cardiac pre-load. This reduced cardiac pre-load leads to reflex tachycardia or myocardial ischaemia, secondary to coronary steal. 10, 11 Nicardipine, a dihydropyridine calcium channel blocker, is a light stable, water soluble selective arterial vasodilator that reduces systemic and coronary artery resistance and increases coronary blood flow. 12 -14 Importantly, the reduction in coronary arterial resistance is greater than that caused by SNP, 15 -17 and nicardipine does not exert a negative inotropic effect or contribute to atrioventricular conduction dysfunction. 18 We aimed to compare the effects of nicardipine and SNP after continuous infusion in an intensive care unit as a treatment for post-CABG hypertension.
Patients and methods

PATIENTS
Patients with a systolic blood pressure (SBP) ≥ 150 mmHg within 6 h of CABG were enrolled in this study. Exclusion criteria were: renal or neurological abnormalities; severely impaired left ventricular function (ejection fraction < 40%); treatment with vasodilators before surgery; and requiring re-operation due to excessive post-operative bleeding.
This study was approved by the institutional review board and all patients gave informed consent.
STANDARD PROCEDURES
All patients received 0.05 mg/kg morphine intramuscularly as a pre-medication 1 h before arriving in the operating theatre. All cardiac drugs, except for digoxin and diuretics, were administered by standard methods. The radial artery of all patients was cannulated in the operating theatre; a pulmonary artery catheter (Swan-Ganz ® , Edwards Lifesciences LLT, Irvine, CA, USA) was inserted via the right internal jugular vein and the monitoring device (HP/CMS 2001, Hewlett-Packard Co., Andover, MA, USA) connected. Cardiac output was measured three times using a thermodilution method, the mean value calculated, and values deviating by more than 10% excluded. Leads II and V 5 of a five-lead electrocardiogram were continuously monitored.
Midazolam (2.5 mg), fentanyl (15 -30 µg/ kg), pancuronium (8 mg) or vecuronium (8 mg) were used to induce anaesthesia, which was maintained with fentanyl (5 -15 µg/kg per h) and isoflurane (0.5 -1.0 vol%). Isosorbide dinitrate (0.5 -1.5 µg/kg per min intravenously) was continuously infused between induction of anaesthesia and end of surgery. After completion of the graft anastomosis, dobutamine (3 -5 µg/kg per min) was administered if the cardiac index was ≤ 2.5 l/min per m 2 , or when myocardial contractility decreased (detected by transoesophageal echocardiography). If the heart rate fell below 65 beats/min after CABG, it was adjusted to 70 -80 beats/min using a pacemaker. Patients were sent to the intensive care unit after surgery.
POST-SURGERY TREATMENT
In the intensive care unit, patients with a SBP ≥ 150 mmHg within 6 h post-surgery were randomly allocated to receive nicardipine (N group) or SNP (S group). Both drugs were infused at 2 µg/kg per min for 10 min. Target blood pressure was a SBP of 120 -140 mmHg for both groups. The dose was increased by 1 µg/kg per min every 10 min if the SBP remained higher than the target blood pressure, and the dose was decreased by 1 µg/kg per min when the target blood pressure was achieved. If SBP was ≤ 120 mmHg or was not within the target blood pressure range despite a dose reduction, drug administration was stopped. Phenylephrine was administered if SBP fell below 100 mmHg.
VARIABLES MEASURED
Use of cardiopulmonary bypass (CPB), number of grafted vessels, incidence of prior myocardial infarction and pre-operative medication, use of dobutamine during surgery and demographic characteristics were recorded. Haemodynamic variables such as SBP, heart rate, mean pulmonary artery pressure, central venous pressure, pulmonary capillary wedge pressure, cardiac index, stroke volume index, left ventricular stroke work index, SVR and pulmonary vascular resistance were recorded just before (T1), and 10 min (T2), 60 min (T3) and 24 h (T4) after drug administration. The amount of post-operative bleeding, urine output, infused fluids and morphine administered for pain control were measured at T3 and T4. Rectal temperature was measured at T1, T3 and T4. Total dose and duration of the infusion for both drugs, and the incidence of phenylephrine administration were also measured. Creatine kinase-MB values at T1 and T4 were measured to compare the effects of both drugs on myocardial ischaemia. Plasma catecholamine levels were measured at T1 and T3.
STATISTICAL ANALYSIS
All measured values are indicated as mean ± SD. The χ 2 test was used to examine the use of cardiopulmonary bypass, incidence of prior myocardial infarction, and use of dobutamine during surgery for the two groups. Repeated measures analysis of variance was used to examine changes in haemodynamic variables by time within each group. The unpaired t-test was used to compare haemodynamic variables between the two groups, and Fisher's exact test was used to compare the incidence of phenylephrine administration between the two groups. P-values < 0.05 were considered statistically significant.
Results
Forty-seven patients were recruited to the study: 26 to the N group and 21 to the S group. No initial differences were seen between the two groups ( Table 1) .
The amount of post-operative bleeding, urine output, infused fluid and morphine administered were not significantly different between the two groups at T3 and T4 ( Table  2 ). Rectal temperature (°C) at T1, T3 and T4 was 36.1 ± 0.6, 36.4 ± 0.6 and 37.0 ± 0.3 in the N group and 36.2 ± 0.7, 36.5 ± 0.6 and 37.2 ± 0.6 in the S group (not significantly different). Table 3 shows the changes in haemodynamic variables. The duration of drug administration was significantly shorter in the N group than in the S group (183.4 ± 150.2 versus 553.8 ± 456.7 min; P = 0.000). The total dose of both drugs administered was also significantly lower in the N group than in the S group (25 028.4 ± 21 206.1 µg versus 55 253.0 ± 58 456.7 µg; P = 0.023). The number of patients requiring phenylephrine administration for hypotension was six in the N group and one in the S group, which was not significantly different. Creatine kinase-MB values were 21.5 ± 19.0 IU/l and 22.3 ± 13.9 IU/l at T1, and 24.7 ± 26.6 IU/l and 18.2 ± 18.9 IU/l at T4 in the N and S groups, respectively. No significant intraor inter-group differences in creatine kinase-MB values were observed. Plasma levels of epinephrine and norepinephrine were significantly higher at T3 than T1 in both groups (P = 0.027; P = 0.004), but were not significantly different between groups (Table 4 ).
Discussion
We found that continuous nicardipine infusion is more effective at controlling blood pressure rise after CABG than continuous SNP infusion. Cardiac and stroke Dobutamine infusion (n) 5 6
Grafted vessels (n) 3.0 ± 0.7 2.7 ± 0.8
All values are expressed as mean ± SD. No statistically significant differences were detected between the two groups. volume indices only increased significantly at T2 and T3 in the N group, and total infusion time and dose were significantly lower than in the S group. In both groups, a decrease in SVR probably resulted in a decrease in SBP. Central venous pressure and pulmonary capillary wedge pressure at T2 were only significantly lower than at T1 in the S group; a decreased pre-load compensated for the positive effect of an afterload reduction on cardiac index. Increased cardiac index at T3 in both groups seems to have resulted from a significantly increased stroke volume index. This is related to a reduction in SVR because no significant change in heart rate was observed in either group.
Factors affecting blood pressure change after surgery, such as CPB usage, body temperature, morphine administration and fluid infused after surgery were controlled, and no significant differences were found between the two groups. Plasma catecholamine levels increased significantly at T3 compared with T1 in both groups, but the difference between groups was not significant. These relationships suggest that the haemodynamic results are closely associated with the pharmacological reactions of nicardipine and SNP. Van Wezel et al. 19 reported that nicardipine was more effective than SNP at preventing myocardial ischaemia, but no difference was found in creatine kinase-MB values between the two groups in this study.
Nicardipine or SNP at 2 µg/kg per min was administered continuously for the first 10 min after SBP increased. SBP was slightly higher than the target blood pressure in the N group only at T2. The dosage regimen in the N group was thought to be appropriate for controlling high blood pressure after CABG, but the number of patients requiring phenylephrine was higher (but not significantly) in the N than the S group. Decreasing the dose of nicardipine if blood pressure falls below a certain level therefore seems necessary because the continuous infusion of nicardipine would lengthen the duration of action. Bernard et al. 20 infused nicardipine continuously for several hours to induce deliberate hypotension during operations to correct scoliosis. They reported that nicardipine, unlike SNP, maintained low blood pressure for a mean of 43 min after discontinuation of therapy, despite a marked decrease in its blood concentration. A different study compared the frequency of dose adjustments after infusion of these two drugs to control hypertension after CABG. 18 The mean frequency of nicardipine dose adjustment was 1.1 and that of SNP was 2.7, suggesting that nicardipine was more convenient for blood pressure control. Halpern et al. 21 reported similar results.
The average duration of drug administration was significantly greater in the S than the N group. Nicardipine, upon infusion, is subject to hepatic metabolism, shows rapid distribution and has a short half-life. 22 Cheung et al. 23 reported that the time required to reach the highest blood concentration of nicardipine was 1 min after the start of infusion. The time required to achieve the maximal effect of blood pressure reduction was 2.5 min after the start of infusion, and the mean effective duration was 24 min. Nicardipine administered by continuous infusion exhibits a relatively slow onset of action and long effective duration, with a redistribution half-life of 17 min and a terminal elimination half-life of 12 h. 24 Several studies compared the efficacy of nicardipine and SNP. 8, 18 The Hess et al. 8 study compared both drugs using bolus or continuous intra-operative infusions, while David et al. 18 investigated the haemodynamics immediately after post-operative infusion. Other studies were on patients undergoing non-cardiac vascular surgery. 25 Our study was different as we only studied patients undergoing CABG surgery; the design allowed us to record the duration of medication, total dose and the effect on haemodynamics after drug administration was stopped (T4).
Sodium nitroprusside causes cyanide toxicity when more than 1.5 mg/kg are given in less than 4 h. 26 The average dose of SNP infused in our study was 55 252 µg per patient. The average weight of patients in the S group was 64 kg, so about 0.86 mg/kg of SNP was infused into each patient in that group. Three patients received more than 1.5 mg/kg in 10 h, but because the infusion duration was long enough, cyanide toxicity was not expected.
Some problems were identified in the result of this study. First, cardiac index, stroke volume index and left ventricular stroke work index at T1 were significantly higher in the N group than the S group. The differences in the changes in haemodynamic variables were significantly different between the two groups at each time, so the differences at T1 might not be the key factor affecting the results. Secondly, the mean duration of drug infusion in the N and S group was 3 h and 9 h, respectively; the haemodynamic variables 24 h after drug administration did not sufficiently reflect the pharmacodynamic effects of the drugs. Thirdly, patients were selected regardless of CPB. No significant differences were observed in the haemodynamic variables of patients with and without CPB in each group, and the ratio of patients with and without CPB was not significantly different between these two groups. We could not, however, rule out the possibility that an unbalanced group composition might have affected the results.
We compared the effects of nicardipine or SNP infusion to control hypertension after CABG. The duration and total dose of drug administered to maintain the target blood pressure were markedly less in the N group. Cardiac index increased significantly in the N group, but not in the S group, immediately after drug administration. Continuous infusion of nicardipine appears to be more effective than SNP for controlling a sudden rise in blood pressure after CABG.
